Weight loss: FDA accepts EnteroMedics' submission of VBLOC neurostim implant

July 26, 2013 by Arezu Sarvestani

FDA regulators accept for review EnteroMedics' premarket approval application for the Maestro VBLOC vagal blocking therapy as a treatment for obesity.

Weight loss: FDA accepts EnteroMedics' submission of VBLOC neurostim implant

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp